verapamil has been researched along with Lipidoses in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edmondson, SD | 1 |
| Zhu, C | 1 |
| Kar, NF | 1 |
| Di Salvo, J | 1 |
| Nagabukuro, H | 1 |
| Sacre-Salem, B | 1 |
| Dingley, K | 1 |
| Berger, R | 1 |
| Goble, SD | 1 |
| Morriello, G | 1 |
| Harper, B | 1 |
| Moyes, CR | 1 |
| Shen, DM | 1 |
| Wang, L | 1 |
| Ball, R | 1 |
| Fitzmaurice, A | 1 |
| Frenkl, T | 1 |
| Gichuru, LN | 1 |
| Ha, S | 1 |
| Hurley, AL | 1 |
| Jochnowitz, N | 1 |
| Levorse, D | 1 |
| Mistry, S | 1 |
| Miller, RR | 1 |
| Ormes, J | 1 |
| Salituro, GM | 1 |
| Sanfiz, A | 1 |
| Stevenson, AS | 1 |
| Villa, K | 1 |
| Zamlynny, B | 1 |
| Green, S | 1 |
| Struthers, M | 1 |
| Weber, AE | 1 |
| Jaffrézou, JP | 1 |
| Levade, T | 1 |
| Thurneyssen, O | 1 |
| Chiron, M | 1 |
| Bordier, C | 1 |
| Attal, M | 1 |
| Chatelain, P | 1 |
| Laurent, G | 1 |
2 other studies available for verapamil and Lipidoses
| Article | Year |
|---|---|
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Fem | 2016 |
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Humans; | 1992 |